Insiders / Lang Matthew
Lang Matthew
CIK 1712069personinsider
Companies
4
First seen
Mar 17, 2021
Last activity
Apr 23, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Structure Therapeutics Inc. · GPCR | 184,614 | — |
| Lyell Immunopharma, Inc. · LYEL | 162,500 | — |
| Metsera, Inc. · MTSR | 0 | — |
| Myovant Sciences Ltd. · MYOV | 0 | — |
All securities held
5 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Lyell Immunopharma, Inc. | Common stock | 162,500 |
| Structure Therapeutics Inc. | Ordinary shares | 184,614 |
Awards
| Company | Security | Shares |
|---|---|---|
| Metsera, Inc. | Restricted units | 12,500 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Lyell Immunopharma, Inc. | Options | 56,250 |
| Structure Therapeutics Inc. | Options | 223,776 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 15, 2021 | Sell Open-market sale | MYOV Myovant Sciences Ltd. Common Shares | $752.0K | -30K -17.06% | 145,865 | medium |
| Aug 15, 2022 | Sell Open-market sale | MYOV Myovant Sciences Ltd. Common Shares | $569.0K | -31K -7.90% | 363,966 | medium |
| Mar 15, 2021 | Exercise Option exercise | MYOV Myovant Sciences Ltd. Common Shares | $233.4K |